Zoetis (ZTS) Total Non-Current Liabilities (2012 - 2026)

Zoetis (ZTS) reported Total Non-Current Liabilities of $11.6 billion for Q1 2026, up 26.21% year-over-year from $9.2 billion in Q1 2025, and down 1.35% quarter-over-quarter from $11.8 billion in Q4 2025.

Zoetis (ZTS) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Total Non-Current Liabilities data on file, last reported at $11.6 billion in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $11.6 billion, up 26.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 billion (up 26.21% YoY), and the FY2025 annual result was $11.8 billion, up 27.63% from the prior year.
  • Total Non-Current Liabilities eased to $11.6 billion in Q1 2026 per ZTS's latest filing, from $11.8 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $11.8 billion in Q4 2025 and troughed at $8.8 billion in Q3 2022.
  • A 5-year average of $9.4 billion and a median of $9.0 billion in 2023 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities declined 12.08% in 2023, then rose 27.63% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $10.3 billion in 2022, then slipped by 12.08% to $9.0 billion in 2023, then increased by 2.45% to $9.2 billion in 2024, then grew by 27.63% to $11.8 billion in 2025, then fell by 1.35% to $11.6 billion in 2026.
  • Business Quant data shows ZTS's Total Non-Current Liabilities at $11.6 billion in Q1 2026, $11.8 billion in Q4 2025, and $9.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 11.64 Bn
Dec 31, 2025 11.80 Bn
Sep 30, 2025 9.50 Bn
Jun 30, 2025 9.23 Bn
Mar 31, 2025 9.22 Bn
Dec 31, 2024 9.25 Bn
Sep 30, 2024 8.90 Bn
Jun 30, 2024 8.98 Bn
Mar 31, 2024 9.02 Bn
Dec 31, 2023 9.02 Bn
Sep 30, 2023 8.77 Bn
Jun 30, 2023 8.85 Bn
Mar 31, 2023 9.05 Bn
Dec 31, 2022 10.26 Bn
Sep 30, 2022 8.77 Bn
Jun 30, 2022 8.94 Bn
Mar 31, 2022 8.96 Bn
Dec 31, 2021 9.10 Bn
Sep 30, 2021 8.77 Bn
Jun 30, 2021 9.46 Bn